ETR:CCAP

CORESTATE Capital Stock Forecast, Price & News

€13.76

-0.25 (-1.78 %)

(As of 04/16/2021 12:00 AM ET)

Add

Compare

Today's Range

€13.75

Now: €13.76▼

€14.17

50-Day Range

€13.21

MA: €14.02▼

€14.86

52-Week Range

€11.70

Now: €13.76▼

€29.58

Volume69,410 shs

Average VolumeN/A

Market Capitalization$353.16 million

P/E RatioN/A

Dividend Yield13.51%

BetaN/A

CORESTATE Capital Holding S.A. is a real estate investment firm specializing in investments in small to medium sized residential portfolios and commercial real estate markets. The firm seeks to invest in an "anti-cyclical" manner in Europe and expand its club-style deals from purely opportunistic to core-plus and value-add investments. The firm offers investment products in real estate funds, co-investments, and club deals. It prefers to invest in Central Europe, Austria, Switzerland, and Germany. CORESTATE Capital Holding S.A. was founded in 2006 and is based in Luxembourg, Luxembourg with additional offices in Zug, Switzerland; London, United Kingdom; Frankfurt, Germany; and Singapore. CORESTATE Capital Holding S.A. operates as a subsidiary of Flygon Holding LLC.

Industry, Sector and Symbol

Stock Exchange ETR

Industry Real Estate Services

Sub-IndustryN/A

SectorReal Estate

Current SymbolETR:CCAP

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.corestate-capital.ch

Phone352 26 6372 20

Employees757

Year FoundedN/A

Debt

Debt-to-Equity Ratio86.87

Current Ratio1.79

Quick Ratio0.83

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$199.20 million

Price / Sales1.77

Cash Flow€3.30 per share

Price / Cash Flow4.17

Book Value€26.72 per share

Price / Book0.51

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares25,666,000

Market Cap$353.16 million

Next Earnings DateN/A

OptionableNot Optionable

Headlines

CORESTATE Capital (ETR:CCAP) Trading Down 0.9%
March 27, 2021 | americanbankingnews.com

Corestate Capital Holding S.A. : Corestate increases the strength of its Sales structures - Philipp Ellebracht named new Group Head of Sales
February 10, 2021 | markets.businessinsider.com

Corestate Capital Holding S.A. : Corestate successfully places Sigma Technopark in Augsburg from its open special AIF 'Opportunity Deutschland I'
January 26, 2021 | markets.businessinsider.com

CORESTATE Capital Holding S.A. (CCAP.DE)
January 7, 2021 | sg.finance.yahoo.com

Why Corestate Capital Holding Sa could be well placed to recover from volatility
August 24, 2020 | uk.finance.yahoo.com

Corestate Capital Holding S.A.
July 9, 2020 | www.barrons.com

DGAP-Stimmrechte: Corestate Capital Holding S.A. (deutsch)
January 30, 2020 | www.finanznachrichten.de

Property Firm Targeted by Muddy Waters Risks Loss of Key Client
October 24, 2019 | finance.yahoo.com

Corestate Capital Holding SA
October 23, 2019 | www.bloomberg.com

See More Headlines

MarketRank^™

Overall MarketRank^™

1.70 out of 5 stars

3.1 Analyst's Opinion

Consensus Rating
CORESTATE Capital has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 2 buy ratings, 2 hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of €25.40, CORESTATE Capital has a forecasted upside of 84.6% from its current price of €13.76.
Amount of Analyst Coverage
CORESTATE Capital has only been the subject of 2 research reports in the past 90 days.

3.1 Community Rank

Outperform Votes
CORESTATE Capital has received 105 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
CORESTATE Capital has received 62 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
CORESTATE Capital has received 62.87% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about CORESTATE Capital and other stocks. Vote “Outperform” if you believe CCAP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CCAP will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Leadership
CORESTATE Capital is a leading dividend payer. It pays a dividend yield of 13.51%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
CORESTATE Capital does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, CORESTATE Capital insiders have not sold or bought any company stock.

0.6 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of CORESTATE Capital is -4.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of CORESTATE Capital is -4.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
CORESTATE Capital has a P/B Ratio of 0.51. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

€13.76

-0.25 (-1.78 %)

(As of 04/16/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive CCAP News and Ratings via Email

Sign-up to receive the latest news and ratings for CCAP and its competitors with MarketBeat's FREE daily newsletter.

CORESTATE Capital (ETR:CCAP) Frequently Asked Questions

Is CORESTATE Capital a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CORESTATE Capital in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CORESTATE Capital stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CCAP, but not buy additional shares or sell existing shares.
View analyst ratings for CORESTATE Capital or view top-rated stocks.

What stocks does MarketBeat like better than CORESTATE Capital?

Wall Street analysts have given CORESTATE Capital a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but CORESTATE Capital wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has CORESTATE Capital's stock price been impacted by COVID-19 (Coronavirus)?

CORESTATE Capital's stock was trading at €38.30 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CCAP shares have decreased by 64.1% and is now trading at €13.76.
View which stocks have been most impacted by COVID-19.

Is CORESTATE Capital a good dividend stock?

CORESTATE Capital pays an annual dividend of €2.50 per share and currently has a dividend yield of 13.51%. CCAP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
View CORESTATE Capital's dividend history.

What price target have analysts set for CCAP?

5 brokers have issued 12 month price targets for CORESTATE Capital's shares. Their forecasts range from €14.00 to €38.00. On average, they expect CORESTATE Capital's stock price to reach €25.40 in the next year. This suggests a possible upside of 84.6% from the stock's current price.
View analysts' price targets for CORESTATE Capital or view top-rated stocks among Wall Street analysts.

Who are CORESTATE Capital's key executives?

CORESTATE Capital's management team includes the following people:

Mr. Rene Parmantier, Chairman of Management Board & CEO (Age 46)
Ms. Silke Hechle, Founder
Mr. Christine Winter, Founder
Mr. Lars Schnidrig L.L.M., M.B.A., CFO & Member of Management Board (Age 49)
Mr. Daniel Lohken, Chief Legal & HR Officer and Member of Management Board (Age 43)
Dr. Florian Sander, Chief Operating Officer
Mr. Nils Huebener, Chief Investment Officer & Member of Management Board
Mr. Sebastian Ernst, Chief Debt Investment Officer & Member of Management Board
Mr. Johannes Marklin, Chief Debt Financing Officer & Member of Management Board
Dr. Kai Gregor Klinger, Chief Markets Officer

Who are some of CORESTATE Capital's key competitors?

Some companies that are related to CORESTATE Capital include Morguard (MRC), Deutsche EuroShop (DEQ), CLS (CLI), St. Modwen Properties (SMP), ADLER Real Estate (ADL), Wall Financial (WFC), Mountview Estates (MTVW), Purplebricks Group (PURP), Foxtons Group (FOXT), Invesque (IVQ.U), Lok'nStore Group (LOK), U and I Group (UAI), Alpha Real Trust (ARTL), The Property Franchise Group (TPFG) and Circle Property (CRC).
View all of CCAP's competitors.

What other stocks do shareholders of CORESTATE Capital own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CORESTATE Capital investors own include Lakeland Industries (LAKE), AbbVie (ABBV), Ovintiv (OVV), SIG (SHI), American Airlines Group (AAL), Apollo Investment (AINV), Aravive (ARAV), Apollo Commercial Real Estate Finance (ARI), Berry (BRY) and 41578029 (BT.L) (BT).

What is CORESTATE Capital's stock symbol?

CORESTATE Capital trades on the ETR under the ticker symbol "CCAP."

What is CORESTATE Capital's stock price today?

One share of CCAP stock can currently be purchased for approximately €13.76.

How much money does CORESTATE Capital make?

CORESTATE Capital has a market capitalization of $353.16 million and generates $199.20 million in revenue each year.

How many employees does CORESTATE Capital have?

CORESTATE Capital employs 757 workers across the globe.

What is CORESTATE Capital's official website?

The official website for CORESTATE Capital is www.corestate-capital.ch.

How can I contact CORESTATE Capital?

The company can be reached via phone at 352 26 6372 20.

This page was last updated on 4/17/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here